• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )

The pharmacokinetics and tissue penetration of ofloxacin.

作者信息

Lockley M R, Wise R, Dent J

出版信息

J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.

DOI:10.1093/jac/14.6.647
PMID:6596301
Abstract

The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, following a 600 mg oral dose. The levels of the compound were measured by a microbiological assay in serum, blister fluid and urine. The compound was rapidly absorbed, the mean maximum concentration of ofloxacin being 10.7 mg/l at 1.2 h. The mean serum elimination half-life was 7 h and 80.3% of the administered compound was recovered in the urine by 48 h. Ofloxacin penetrated the blister fluid well, the mean peak level being 5.2 mg/l at 5.3 h.

摘要

对6名健康志愿者口服600毫克4-喹诺酮类药物氧氟沙星后的药代动力学进行了研究。通过微生物测定法测定血清、水疱液和尿液中该化合物的水平。该化合物吸收迅速,氧氟沙星的平均最大浓度在1.2小时时为10.7毫克/升。血清平均消除半衰期为7小时,48小时内80.3%的给药化合物在尿液中回收。氧氟沙星能很好地渗透到水疱液中,平均峰值水平在5.3小时时为5.2毫克/升。

相似文献

1
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
2
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.四种喹诺酮类药物(包括静脉注射的依诺沙星)的比较药代动力学和组织穿透性。
Infection. 1986;14 Suppl 3:S196-202. doi: 10.1007/BF01667843.
3
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.氧氟沙星:禁食和非禁食状态下的血清及皮肤水疱液药代动力学
J Antimicrob Chemother. 1986 Jun;17(6):795-800. doi: 10.1093/jac/17.6.795.
4
Pharmacokinetics and tissue penetration of enoxacin.依诺沙星的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9. doi: 10.1128/AAC.26.1.17.
5
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.新型广谱抗菌剂氧氟沙星的多剂量药代动力学
Clin Ther. 1986;8(6):632-45.
6
The pharmacokinetics and tissue penetration of norfloxacin.诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.
7
Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.肾衰竭患者单次口服氧氟沙星的药代动力学。
Chemioterapia. 1986 Dec;5(6):391-3.
8
The pharmacokinetics of ofloxacin and a review of its tissue penetration.氧氟沙星的药代动力学及其组织穿透性综述
J Antimicrob Chemother. 1988 Sep;22 Suppl C:59-64. doi: 10.1093/jac/22.supplement_c.59.
9
The comparative pharmacokinetics of five quinolones.五种喹诺酮类药物的比较药代动力学
J Antimicrob Chemother. 1986 Nov;18 Suppl D:71-81. doi: 10.1093/jac/18.supplement_d.71.
10
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.

引用本文的文献

1
Safety evaluation of a new formulation of intravenous ofloxacin.氧氟沙星静脉注射新制剂的安全性评估
Drugs. 1995;49 Suppl 2:497-8. doi: 10.2165/00003495-199500492-00148.
2
Single dose UTI prophylaxis in transurethral surgery. Oral ofloxacin vs parenteral cefotaxime.经尿道手术中单次剂量的尿路感染预防。口服氧氟沙星与静脉注射头孢噻肟的比较。
Drugs. 1995;49 Suppl 2:480-2. doi: 10.2165/00003495-199500492-00142.
3
A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.一项比较每日两次环丙沙星与每日一次氧氟沙星序贯疗法的随机、多国研究。
Infection. 1995 Jul-Aug;23(4):227-33. doi: 10.1007/BF01781203.
4
Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.新合成喹诺酮类药物AM - 1155、司帕沙星和氧氟沙星的抗分枝杆菌活性比较
Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63. doi: 10.1128/AAC.37.6.1259.
5
Intravitreal penetration of oral pefloxacin in humans.口服培氟沙星在人体玻璃体内的渗透情况。
Int Ophthalmol. 1993 Aug;17(4):217-22. doi: 10.1007/BF01007743.
6
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.左氧氟沙星对结核分枝杆菌的体外及在人巨噬细胞中的抑制和杀菌活性。
Antimicrob Agents Chemother. 1994 May;38(5):1161-4. doi: 10.1128/AAC.38.5.1161.
7
Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.慢性呼吸道感染患者唾液中氧氟沙星浓度的有效监测。
Antimicrob Agents Chemother. 1994 May;38(5):1140-3. doi: 10.1128/AAC.38.5.1140.
8
Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis.氟喹诺酮类药物对感染结核分枝杆菌的小鼠巨噬细胞的活性比较。
Antimicrob Agents Chemother. 1995 Mar;39(3):750-3. doi: 10.1128/AAC.39.3.750.
9
Quinolones in Salmonella typhi infection.喹诺酮类药物在伤寒沙门菌感染中的应用
Drugs. 1993;45 Suppl 3:119-24. doi: 10.2165/00003495-199300453-00020.
10
Disk susceptibility of ofloxacin, a new carboxyquinolone.新型羧基喹诺酮类药物氧氟沙星的磁盘药敏试验
J Clin Microbiol. 1985 Nov;22(5):786-8. doi: 10.1128/jcm.22.5.786-788.1985.